RD
Robert Driscoll Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
26
Avg Return
Past Year
Past Year
19%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
80%
Neutral
10%
Negative
10%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Underperform
Initiated
| $7 |
49%
downside
| 1 | +7.3% |
0
%
| 26 Feb ‘26 5 days ago |
|
|
|
Outperform
Maintained
| $30 |
199%
upside
| 1 | -17% |
0
%
| 25 Feb ‘26 6 days ago |
|
|
|
Neutral
Maintained
| $11 |
18%
downside
| 1 | – |
–
| 25 Feb ‘26 6 days ago |
|
|
|
Outperform
Maintained
| $52 |
52%
upside
| 1 | +12% |
0
%
| 18 Feb ‘26 13 days ago |
|
|
|
Outperform
Maintained
| $53 |
61%
upside
| 2 | +23% |
0
%
| 13 Feb ‘26 18 days ago |
|
|
|
Outperform
Maintained
| $7 |
724%
upside
| 1 | +29% |
0
%
| 10 Feb ‘26 21 days ago |
|
|
|
Outperform
Maintained
| $19 |
165%
upside
| 1 | +31% |
0
%
| 4 Feb ‘26 27 days ago |
|
|
|
Outperform
Initiated
| $70 |
16%
upside
| 1 | +45% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $34 |
116%
upside
| 1 | +26% |
0
%
| 9 Dec ‘25 2 months ago |
|